Abstract

To estimate the risk of mother-to-child transmission (MTCT) of HIV-1 and evaluate the effect of preventive methods on vertical transmission of HIV, such as: use of AZT by pregnant women during the prenatal period, labor and delivery; use of AZT in newborns; replacement of breastfeeding by formula; and indication of cesarean section. This was a cohort study. Data was collected from medical records of pregnant women and of children followed at reference health centers for HIV/AIDS patients. To estimate the risk of MTCT we divided the number of mothers whose children acquired the virus through vertical transmission by the total number of mothers included in the study; the relative risks were calculated with a CI=95%. Occurrence of transmission was regarded as a dependent variable, the other factors (maternal age, use of oral AZT and use of AZT syrup, gestational age and breastfeeding) were considered as independent variables. Mantel-Haenszel's techniques were used in this analysis to control the possible effect of some variables. The occurrence of HIV in MTCT was identified in 144 children. Fourteen were classified as infected. Risk of transmission was of 0.097 (95% CI; 0.030-0.163). The risk of HIV vertical transmission was smaller in women under thirty years of age when compared with older ones. In the univariate analysis, the MTCT risk was significantly associated with maternal age, prenatal care, use of oral AZT and use of AZT syrup, gestational age and breastfeeding. This study showed that the implementation of preventive measures is important in the prevention of mother-to-child transmission of HIV, providing a risk reduction of almost 40% when compared to that before use of these preventive measures.

Highlights

  • To estimate the risk of mother-tochild transmission (MTCT) we divided the number of mothers whose children acquired the virus through vertical transmission by the total number of mothers included in the study; the relative risks were calculated w ith a CI=95%

  • The occurrence of human immunodeficiency virus (HIV) in MTCT was identified in 144 children

  • The risk of HIV vertical transmission was smaller in women under thirty years of age w hen compared w ith older ones

Read more

Summary

Artigo Original

TRANSMISSÃO MATERNO -INFANTIL DO VÍRUS DA IMUNODEFICIÊNCIA HUMANA : AVALIAÇÃO DE MEDID AS DE CONTROLE NO MUNICÍPIO DE SANTOS. Uma dessas intervenções foi a aplicação do protocolo 076 do Aids Clinical Trial Group, estudo clínico publicado em 1994, no qual se demonstrou que a administração da Zidovudina para a mulher infectada durante a gestação, parto e para o recém-nascido nas primeiras semanas de vida reduzia a transmissão materno-infantil do HIV em 67,5%13. Nos casos em que as mulheres tiveram mais de um filho (não gemelares), no período do estudo, somente uma das gestações foi incluída, por sorteio. Análise estatística Para estimar o risco de transmissão materno-infantil do HIV (com intervalo de 95% de confiança), dividiu-se o número de mães cujos filhos adquiriram o vírus por transmissão vertical pelo número de mães incluídas no estudo. Os resultados apresentados a seguir são referentes às 144 mulheres/crianças em que foi possível confirmar ou afastar a ocorrência de transmissão materno-infantil (com base nos critérios relatados anteriormente). Entre as médias das Tabela 2 – Riscos relativos de transmissão vertical do HIV associados à realização do pré-natal e às medidas preventivas

Variável de estratificação
HUMAN IMMUNODEFICIENCY VIRUS
METHODS
RESULTS
CONCLUSION
Acquir Immune Defic Syndr Hum Retrovirol
Immune Defic Syndr Hum Retrovirol
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call